Monitoring cancer stem cells: insights into clinical oncology

Cancer stem cells (CSCs) are a small, characteristically distinctive subset of tumor cells responsible for tumor initiation and progression. Several treatment modalities, such as surgery, glycolytic inhibition, driving CSC proliferation, immunotherapy, and hypofractionated radiotherapy, may have the...

Full description

Bibliographic Details
Main Authors: Lin, ShuChen, Xu, YingChun, Gan, ZhiHua, Han, Kun, Hu, HaiYan, Yao, Yang, Huang, MingZhu, Min, DaLiu
Format: Online
Language:English
Published: Dove Medical Press 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755432/
id pubmed-4755432
recordtype oai_dc
spelling pubmed-47554322016-02-29 Monitoring cancer stem cells: insights into clinical oncology Lin, ShuChen Xu, YingChun Gan, ZhiHua Han, Kun Hu, HaiYan Yao, Yang Huang, MingZhu Min, DaLiu Perspectives Cancer stem cells (CSCs) are a small, characteristically distinctive subset of tumor cells responsible for tumor initiation and progression. Several treatment modalities, such as surgery, glycolytic inhibition, driving CSC proliferation, immunotherapy, and hypofractionated radiotherapy, may have the potential to eradicate CSCs. We propose that monitoring CSCs is important in clinical oncology as CSC populations may reflect true treatment response and assist with managing treatment strategies, such as defining optimal chemotherapy cycles, permitting pretreatment cancer surveillance, conducting a comprehensive treatment plan, modifying radiation treatment, and deploying rechallenge chemotherapy. Then, we describe methods for monitoring CSCs. Dove Medical Press 2016-02-11 /pmc/articles/PMC4755432/ /pubmed/26929644 http://dx.doi.org/10.2147/OTT.S96645 Text en © 2016 Lin et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Lin, ShuChen
Xu, YingChun
Gan, ZhiHua
Han, Kun
Hu, HaiYan
Yao, Yang
Huang, MingZhu
Min, DaLiu
spellingShingle Lin, ShuChen
Xu, YingChun
Gan, ZhiHua
Han, Kun
Hu, HaiYan
Yao, Yang
Huang, MingZhu
Min, DaLiu
Monitoring cancer stem cells: insights into clinical oncology
author_facet Lin, ShuChen
Xu, YingChun
Gan, ZhiHua
Han, Kun
Hu, HaiYan
Yao, Yang
Huang, MingZhu
Min, DaLiu
author_sort Lin, ShuChen
title Monitoring cancer stem cells: insights into clinical oncology
title_short Monitoring cancer stem cells: insights into clinical oncology
title_full Monitoring cancer stem cells: insights into clinical oncology
title_fullStr Monitoring cancer stem cells: insights into clinical oncology
title_full_unstemmed Monitoring cancer stem cells: insights into clinical oncology
title_sort monitoring cancer stem cells: insights into clinical oncology
description Cancer stem cells (CSCs) are a small, characteristically distinctive subset of tumor cells responsible for tumor initiation and progression. Several treatment modalities, such as surgery, glycolytic inhibition, driving CSC proliferation, immunotherapy, and hypofractionated radiotherapy, may have the potential to eradicate CSCs. We propose that monitoring CSCs is important in clinical oncology as CSC populations may reflect true treatment response and assist with managing treatment strategies, such as defining optimal chemotherapy cycles, permitting pretreatment cancer surveillance, conducting a comprehensive treatment plan, modifying radiation treatment, and deploying rechallenge chemotherapy. Then, we describe methods for monitoring CSCs.
publisher Dove Medical Press
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755432/
_version_ 1613539302727221248